Gilead says its twice-yearly shot minimize HIV infections by 96% in trial
A pharmacist holds a vial of lenacapavir, the brand new HIV prevention injectable drug. Nardus Engelbrecht | AP Gilead‘s…
End of content
End of content
Gilead Sciences Inc